Arca
Skip to content
Tools
Tools

PTGS2: Cyclooxygenase-2

Protein in Canis lupus familiaris that 5 drugs act on.

  • Drugs that act on it: 5
  • Approved: 0
  • In phases 1 to 3: 4
  • Sponsors: 0

Who is on it, and how far along

Every drug ChEMBL records acting on PTGS2, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 5

Approved0

    Phase 30

      Phase 24

      • Firocoxib
      • Mavacoxib
      • Robenacoxib
      • Tepoxalin

      Phase 10

        Preclinical or unknown1

        • Enflicoxib

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. All act as: Cyclooxygenase-2 inhibitor.
        FirocoxibPhase 2—Small moleculeInhibitor0
        MavacoxibPhase 2—Small moleculeInhibitor0
        RobenacoxibPhase 2—Small moleculeInhibitor0
        TepoxalinPhase 2—Small moleculeInhibitor0
        EnflicoxibPreclinical or unknown—Small moleculeInhibitor0

        Genes and related targets

        Complexes and families that share a gene with this target
        Genes
        PTGS2

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL4033, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-18. ChEMBL and Open Targets

        Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.